These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22718488)

  • 41. Takayasu's arteritis and ulcerative colitis.
    Gearry R; Carne P; Frizelle F
    N Z Med J; 2003 Mar; 116(1170):U359. PubMed ID: 12658317
    [No Abstract]   [Full Text] [Related]  

  • 42. Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease.
    Steenholdt C; Palarasah Y; Bendtzen K; Teisner A; Brynskov J; Teisner B; Nielsen CH
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1172-83. PubMed ID: 23650912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab.
    Chiba M; Ono I; Wakamatsu H; Wada I; Suzuki K
    Dig Endosc; 2013 Nov; 25(6):622-5. PubMed ID: 24164601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infliximab in the treatment of severe ulcerative colitis.
    Jiménez JM
    Rev Esp Enferm Dig; 2004 Feb; 96(2):89-93. PubMed ID: 15255017
    [No Abstract]   [Full Text] [Related]  

  • 45. Infliximab in refractory severe ulcerative colitis: a case report.
    Bossa F; Caserta L; Selvaggi F; Riegler G
    Minerva Gastroenterol Dietol; 2005 Sep; 51(3):261-2. PubMed ID: 16280968
    [No Abstract]   [Full Text] [Related]  

  • 46. Infliximab for refractory ulcerative colitis.
    Chey WY; Hussain A; Ryan C; Potter GD; Shah A
    Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infliximab for ulcerative colitis.
    Actis GC
    Am J Gastroenterol; 2003 Mar; 98(3):709. PubMed ID: 12650824
    [No Abstract]   [Full Text] [Related]  

  • 48. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
    Oussalah A; Evesque L; Laharie D; Roblin X; Boschetti G; Nancey S; Filippi J; Flourié B; Hebuterne X; Bigard MA; Peyrin-Biroulet L
    Am J Gastroenterol; 2010 Dec; 105(12):2617-25. PubMed ID: 20736936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infliximab for ulcerative colitis following liver transplantation.
    Lal S; Steinhart AH
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31.
    Steenholdt C; Al-Khalaf M; Ainsworth MA; Brynskov J
    J Crohns Colitis; 2012 Apr; 6(3):358-61. PubMed ID: 22405174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis.
    Van Hauwaert V; Meers S; Verhoef G; Tousseyn T; Sagaert X; Vermeire S; Rutgeerts P; Van Assche G
    J Crohns Colitis; 2010 Dec; 4(6):683-6. PubMed ID: 21122582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Case of ulcerative colitis refractory to intravenous cyclosporine therapy successfully treated with infliximab].
    Tsuya R; Motoya S; Tanaka H; Nakagaki S; Nishioka H; Hagiwara T; Kozawa H; Kurokawa S; Ambo T; Imamura A
    Nihon Shokakibyo Gakkai Zasshi; 2008 May; 105(5):679-85. PubMed ID: 18460856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infliximab for refractory ulcerative proctitis.
    Bouguen G; Roblin X; Bourreille A; Feier L; Filippi J; Nancey S; Bretagne JF; Flourié B; Hébuterne X; Bigard MA; Siproudhis L; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1178-85. PubMed ID: 20222911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infliximab for the treatment of ulcerative colitis.
    Hyde C; Bryan S; Juarez-Garcia A; Andronis L; Fry-Smith A
    Health Technol Assess; 2009 Oct; 13 Suppl 3():7-11. PubMed ID: 19846023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
    Herrlinger KR; Barthel DN; Schmidt KJ; Büning J; Barthel CS; Wehkamp J; Stange EF; Fellermann K
    Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Infliximab as treatment for a severe outbreak of ulcerative colitis].
    Ruiz P; San Salvador P; Ortiz de Zárate J; Cabezudo P; Marcé L; Polo F; Blanco S; Orive V
    Gastroenterol Hepatol; 2004; 27(7):430-1. PubMed ID: 15461945
    [No Abstract]   [Full Text] [Related]  

  • 60. Infliximab for ulcerative colitis.
    Chey WY; Shah A
    J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.